Atara Biotherapeutics Inc. Annual stock financials by MarketWatch. View the latest ATRA financial statements, income statements and financial ratios.

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) characterized by its abnormal promyelocytes infiltrating bone marrow and other hematopoietic organs and its ...

Targeted cancer therapies work by blocking a single oncogenic pathway to halt tumor growth. But because cancerous tumors have the unique ability to activate alternative pathways, they are often able ...

This past spring, Congress passed a number of important tax provisions that will impact how taxpayers manage their assets and estates. One of particular significance is the American Tax Relief Act of ...

This report should not be treated as legitimate news and instead it should be recognized for what it truly is: a sophisticated public relations campaign designed to manipulate public opinion and ...

) has been revised to $11.90 / share. This is an increase of 25.00% from the prior estimate of $9.52 dated April 25, 2026. The price target is an average of many targets provided by analysts. The ...

View Atara Biotherapeutics Inc ATRA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Atara Biotherapeutics ATRA shares have rallied 82.4% in a month, primarily driven by a positive regulatory update earlier in May on its lead product candidate, tabelecleucel (tab-cel). The update ...